RVMD Revolution Medicines, Inc. Common Stock
US$191.36
+0.49%
Latest close
Trend channel, buy level and 3-month target. Information only, not financial advice.
Below the channel · 9-month channel rising
Closed below support (US$213.96). Treat the buy level with caution.
- 9-month channel
- US$213.96 – US$226.84 · rising, more than +100% a year
- Price in channel
- −176% (0% = floor, 100% = ceiling)
- Ceiling overhead
- US$226.84
- Published levels
- Buy and target are not from this channel — see below.
Price history, with the path projected 3 months forward
Updated 4:13 AM ET (56 h ago)
- Daily close
- Upper trend line (9 months)
- Lower trend line (9 months)
- Dashed after today: projected 3 months
- Our buy
- Our target
Suggested path
Buy at or below
US$190.43
level as at 1 Nov 2026
Our target
US$246.14
by 28 Jan 2027
Projected move
29.3%
gross, before costs
Price is between our buy and target.
Target: the projected upper line.
This move size: reached in 38% of 21 past stretches, typically in 90 days. (0.33% per day)
- Upper line touches
- 3
- Lower line touches
- 2
- Fit confidence
- 58%
- Fitted
- 1 Nov 2026
Company information
About Revolution Medicines, Inc.
Revolution Medicines, Inc. is a US-listed company, classified under Biological Products, (No Diagnostic Substances), with principal offices in REDWOOD CITY, CA.
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)
- Country
- United States
Trend lines are fitted to past swing highs and lows and may not continue. Information only, not financial advice.